Cannabis acquisition strategy
Search documents
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
Globenewswire· 2025-07-09 12:30
Core Insights - THC Therapeutics, Inc. has acquired STHoldings Group LLC, the parent company of SugarTop Buddery, in an all-share transaction valued at approximately $3 million [1][2][5] - This acquisition is part of THCT's ongoing roll-up strategy to expand its operations in the cannabis industry, particularly in Oregon [2][8] - SugarTop Buddery, founded in 2015, is recognized for its community-driven approach and commitment to artistry, equity, and sustainability [3][10] Company Overview - SugarTop Buddery has generated approximately $2.1 million in revenue in 2024, with peak performance reaching around $4.3 million in 2022 [4] - The brand is known for its innovative product offerings, including stylish pre-rolls and collaborations with artists, and has a strong emphasis on social equity and women in cannabis [7][10] - The acquisition will provide SugarTop Buddery with the necessary capital and resources to expand nationally and internationally [4][5] Strategic Implications - The acquisition enhances THCT's portfolio by adding a resilient and culturally significant brand that aligns with its values-driven strategy [5][8] - Anna Kaplan, CEO of SugarTop Buddery, will play a key role in shaping THCT's consumer strategy across its entire portfolio [8] - THCT aims to create a bi-coastal, vertically integrated national cannabis platform by acquiring proven operators and market-leading brands [8][13]